Shortly after receiving approval from the U.S. Food & Drug Administration, Abbott selected St. Luke's Heart & Vascular Center as one of the first sites in the nation – and the only site in the Lehigh Valley region – to use the world's first dissolving heart stent to treat Coronary Artery Disease (CAD), which affects 15 million people in the United States.
Abbott joins a long list of medical-device companies in selecting St. Luke's Heart & Vascular Center to pioneer it's product.
The Absorb dissolving stent treats coronary artery disease like a metallic stent, but then disappears after the artery is healed, leaving no metal behind to restrict natural vessel motion.
How It Works
St. Luke's Heart & Vascular Center stands among the first healthcare providers in the country to pioneer:
- Transcatheter aortic valve replacement (TAVR) – only available in the Lehigh Valley at St. Luke's.
- Mitra Clip percutaneous mitral valve repair – only available in the Lehigh Valley at St. Luke's.
- The world's smallest Pacemaker, The Micra Pacemaker – only available in the Lehigh Valley at St. Luke's.
- And now, Abbott's dissolving stent
From Open Heart Surgery to Naturally Dissolving Stents
If you or someone you love, has coronary artery disease, here’s some good news for you… Read more
The Case of the Disappearing Stent
Psst! It’s great news!… Read more
St. Luke’s University Health Network First – and Only – Hospital Network in the Lehigh Valley to Offer Dissolvable Stents for the Treatment of Coronary Artery Disease... Read more
For more information, call St. Luke's InfoLink today at